Overview

Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium Versus Placebo in Participants With Knee Osteoarthritis Pain

Status:
Not yet recruiting

Trial end date:
2023-01-06

Target enrollment:

Participant gender:

Summary

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee osteoarthritis pain. Study details include: - The study duration will be up to 28 weeks per participant - The treatment duration will be 6 weeks. - The visit frequency will be twice weekly during treatment..

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Paradigm Biopharmaceuticals USA (INC)

Treatments:

Pentosan Sulfuric Polyester